Harbour BioMed
Kathy Ma is a seasoned professional in corporate communications and scientific research, currently serving as the Head of Corporate Communications at both HARBOUR BIOMED and Nona Biosciences since October 2023. Prior to these roles, Kathy held the position of Director and Associate Director at WuXi AppTec from April 2019 to October 2023, and served as Chief Editor at Tencent from September 2017 to April 2019. Kathy's earlier experience includes working as an Editorial Project Manager at Elsevier and a Research Associate at The Chinese University of Hong Kong. Kathy earned a PhD in Cardiology and Vascular Biology from The Chinese University of Hong Kong, an MPhil in Cardiac Physiology from The University of Hong Kong, and a Bachelor's degree in Pharmacy from Peking University.
This person is not in any teams
This person is not in any offices
Harbour BioMed
1 followers
Harbour BioMed is an Immune-Driven Global Bio-therapeutics Company discovering, developing and delivering Innovative Therapeutics for Oncology and Immunology. The company's discovery and development programs are centered around its two patented transgenic mouse platforms for human antibody discovery - the H2L2 and the HCAb.